Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
80 participants
INTERVENTIONAL
2020-08-21
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants who are eligible will undergo baseline language testing, an MRI, and will be randomized into one of 4 treatment groups: SET for 3 weeks, SET for 4.5 weeks, SET for 6 weeks, and no treatment (control group).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT02094014
Treatments of Acquired Apraxia of Speech
NCT01483807
Mirror Speech Entrainment: A Novel Technique for Voice Personalized Speech Entrainment for Nonfluent Aphasia
NCT06829420
Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia
NCT01163461
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
NCT05653440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SET (Speech Entrainment Therapy) 3 weeks
SET (Speech Entrainment Therapy) 3 weeks
3 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
SET (Speech Entrainment Therapy) 4.5 weeks
SET (Speech Entrainment Therapy) 4.5 weeks
4.5 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
SET (Speech Entrainment Therapy) 6 weeks
SET (Speech Entrainment Therapy) 6 weeks
6 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
No Therapy 6 weeks
No Therapy 6 Weeks
Participants will not be getting any SET for 6 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SET (Speech Entrainment Therapy) 3 weeks
3 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
SET (Speech Entrainment Therapy) 4.5 weeks
4.5 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
SET (Speech Entrainment Therapy) 6 weeks
6 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
No Therapy 6 Weeks
Participants will not be getting any SET for 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of left hemisphere stroke in clinical imaging (CT/MRI) and NIHSS
* Participants must have spoken English as their primary language.
* 21-81 years old
* Pre-stroke modified Rankin Scale (mRS)= 2 or less
* Post-stroke mRS= 4 or less.
* At least 6 months post-stroke.
* Non-fluent aphasia (WAB-R Comprehension score \>4 and WAB-R Fluency score \<6).
* Technological compatibility (to be determined by clinical judgment of SLP)
Exclusion Criteria
* Severe dysarthria (determined via SLP clinical judgment from spontaneous speech tasks on the ASRS 3.0).
* Global aphasia.
* History of right-hemisphere strokes or brain stem/cerebellar strokes with persistent deficits (as evidenced by MRI/CT and NIHSS).
* Uncorrectable hearing as determined by the SLP's clinical judgment.
* Uncorrectable vision.
* Contraindications to MRI or inability to complete the MRI scanning session.
* Women who are pregnant.
21 Years
81 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonardo Bonilha, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
University of South Carolina
Columbia, South Carolina, United States
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00091924
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.